Accelerating MedTech Clinical Trials: New models, real‑world delivery, & why the UK can lead

Undertaking clinical trials for MedTech devices in the UK has traditionally been expensive and slow. This webinar (hosted by Orthopaedic Research UK, in association with clinical trials specialist VerIQ and the National Orthopaedic Alliance) will explore how the delivery of clinical studies in health tech and medical devices can be transformed and the UK become a leader in this area.

It will feature a distinguished group of speakers representing industry, regulation, clinical practice, and clinical research delivery.

If you are involved with an MSK MedTech startup, or a clinician or researcher thinking about starting commercial studies, we highly recommend attending this free webinar.

Webinar agenda:

1. Introduction – Why the UK is well positioned to lead in MedTech clinical trials and the importance of new delivery models (Joe Dupere, CEO, VerIQ).
2. Industry perspective on barriers, opportunities, and what developers need from the UK ecosystem (Paul Gibbons, Chair of the Orthopaedics Committee, ABHI).
3. UK regulatory environment and the role of regulation in enabling innovation and efficient evidence generation (Daniel Hill, Deputy Head of Clinical Investigations, Innovation and Compliance Group, MHRA)
4. Clinical site delivery, NHS participation, and the importance of coordinated research infrastructure (National Orthopaedic Alliance representative TBC)
5. Multinational sponsor perspective on conducting MedTech clinical research in the UK (Jamie McDonald, Associate Director, Clinical Science & External Research, DePuy Synthes Companies of Johnson & Johnson)
6. Q&A (hosted by Martin Thomas, Head of Strategy, ORUK)